FANDANGO

Trial Description: 
ENGOT-EN1/FANDANGO: A Randomized Phase II Trial of First-line Combination Chemotherapy With Nintedanib / Placebo for Patients With Advanced or Recurrent Endometrial Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Recurrent Endometrial
Trial Status: 
Recruiting
Contact person: